BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8580635)

  • 1. Severe Rh(D) immunization: anti-D quantitation and treatment possibilities during pregnancy and after birth.
    Gottvall T; Hildén JO; Nelson N; Filbey D
    Acta Paediatr; 1995 Nov; 84(11):1315-7. PubMed ID: 8580635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
    Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
    Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn.
    Gottvall T; Hildén JO; Selbing A
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):300-6. PubMed ID: 8160535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of severe alloimmunization.
    Bennebroek Gravenhorst J
    Vox Sang; 1994; 67 Suppl 3():235-8. PubMed ID: 7975499
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis.
    Maayan-Metzger A; Schwartz T; Sulkes J; Merlob P
    Arch Dis Child Fetal Neonatal Ed; 2001 Jan; 84(1):F60-2. PubMed ID: 11124929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions.
    Saade GR; Moise KJ; Belfort MA; Hesketh DE; Carpenter RJ
    Fetal Diagn Ther; 1993; 8(3):161-4. PubMed ID: 8240686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
    Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
    Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden.
    Gottvall T; Filbey D
    Acta Obstet Gynecol Scand; 2008; 87(8):843-8. PubMed ID: 18704776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhesus immunization in pregnancy: a review.
    Duerbeck NB; Seeds JW
    Obstet Gynecol Surv; 1993 Dec; 48(12):801-10. PubMed ID: 8309663
    [No Abstract]   [Full Text] [Related]  

  • 13. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.
    Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA
    Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?
    Chitkara U; Bussel J; Alvarez M; Lynch L; Meisel RL; Berkowitz RL
    Obstet Gynecol; 1990 Oct; 76(4):703-8. PubMed ID: 2120641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of rhesus alloimmunization in pregnancy.
    Moise KJ
    Obstet Gynecol; 2008 Jul; 112(1):164-76. PubMed ID: 18591322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
    Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
    Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Rh antibodies in haemolytic disease of the newborn.
    Hadley AG; Kumpel BM
    Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.